| Human cortex spheroid with a functional blood brain barrier for high-throughput neurotoxicity screening and disease modeling G Nzou, RT Wicks, EE Wicks, SA Seale, CH Sane, A Chen, SV Murphy, ... Scientific reports 8 (1), 1-10, 2018 | 167 | 2018 |
| Drug compound screening in single and integrated multi-organoid body-on-a-chip systems A Skardal, J Aleman, S Forsythe, S Rajan, S Murphy, M Devarasetty, ... Biofabrication 12 (2), 025017, 2020 | 158 | 2020 |
| Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform SAP Rajan, J Aleman, MM Wan, NP Zarandi, G Nzou, S Murphy, ... Acta biomaterialia 106, 124-135, 2020 | 111 | 2020 |
| Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model V Sokolova, G Nzou, SB van der Meer, T Ruks, M Heggen, K Loza, ... Acta biomaterialia 111, 349-362, 2020 | 60 | 2020 |
| Multicellular 3D neurovascular unit model for assessing hypoxia and neuroinflammation induced blood-brain barrier dysfunction G Nzou, RT Wicks, NR VanOstrand, GA Mekky, SA Seale, A El-Taibany, ... Scientific reports 10 (1), 9766, 2020 | 58 | 2020 |
| Evaluation of the Structure–Activity Relationship of Microtubule-Targeting 1,2,4-Triazolo[1,5-a]pyrimidines Identifies New Candidates for Neurodegenerative … K Oukoloff, G Nzou, C Varricchio, B Lucero, T Alle, J Kovalevich, L Monti, ... Journal of medicinal chemistry 64 (2), 1073-1102, 2021 | 22 | 2021 |
| In Zimbabwe, we don't cry for lions. G Nzou International New York Times, NA-NA, 2015 | 18 | 2015 |
| Correction of microtubule defects within Aβ plaque‐associated dystrophic axons results in lowered Aβ release and plaque deposition Y Yao, G Nzou, T Alle, W Tsering, S Maimaiti, JQ Trojanowski, VMY Lee, ... Alzheimer's & Dementia 16 (10), 1345-1357, 2020 | 13 | 2020 |
| Microtubule-Stabilizing 1,2,4-Triazolo[1,5-a]pyrimidines as Candidate Therapeutics for Neurodegenerative Disease: Matched Molecular Pair Analyses and … T Alle, C Varricchio, Y Yao, B Lucero, G Nzou, S Demuro, M Muench, ... Journal of Medicinal Chemistry 66 (1), 435-459, 2022 | 8 | 2022 |
| Fundamental neurovascular components for the development of complex and dynamic in vitro brain equivalent models G Nzou, MC Seeds, RT Wicks, AJ Atala J. Alzheimers Neurodegener. Dis 5, 21, 2019 | 6 | 2019 |
| Multicellular 3D neurovascular unit model for assessing hypoxia and neuroinflammation induced blood-brain barrier dysfunction. Sci Rep 10 (1): 9766 G Nzou, RT Wicks, NR VanOstrand, GA Mekky, SA Seale, A El-Taibany, ... | 5 | 2020 |
| Author Correction: Multicellular 3D Neurovascular Unit Model for Assessing Hypoxia and Neuroinflammation Induced Blood-Brain Barrier Dysfunction G Nzou, RT Wicks, NR VanOstrand, GA Mekky, SA Seale, ELT Aya, ... Scientific Reports 10, 2020 | 2 | 2020 |
| Blood brain barrier model and methods of making and using the same RT Wicks, A Atala, G Nzou, EE Wicks US Patent App. 17/643,441, 2022 | | 2022 |
| Alzheimer’s in Screening Academia: to Disease In From Vivo High-Throughput Testing KR Brunden, G Nzou, C Ballatore Alzheimer's Disease Drug Development: Research and Development Ecosystem, 34, 2022 | | 2022 |
| Blood brain barrier model and methods of making and using the same RT Wicks, A Atala, G Nzou, EE Wicks US Patent 11,230,702, 2022 | | 2022 |
| 3D Neurovascular Spheroid for Assessing Hypoxia Induced Blood-Brain Barrier Dysfunction RT Wicks, G Nzou, N VanOstrand, G Mekky, S Seale, E Wicks, ... Neurosurgery 67 (Supplement_1), 2020 | | 2020 |
| The Development of a Multicellular Three-Dimensional Neurovascular Unit Model for Studying Blood-Brain Barrier Integrity in Disease Pathologies G Nzou Wake Forest University, 2019 | | 2019 |
| The Development of a Human Cortex Model for High Throughput Neurotoxicity and Drug Screening G Nzou, SS Seale, EE Wicks, RR Wicks, JD Jackson, AJ Atala TISSUE ENGINEERING PART A 23, S106-S106, 2017 | | 2017 |
| Adhesive Film Based Multi-organoid Body-on-a-chip Platform For Assessing Drug Efficiency And Toxicity S Rajan, J Aleman, M Wan, NP Zarandi, U Gandhi, G Nzou, CE Bishop, ... TISSUE ENGINEERING PART A 23, S116-S116, 2017 | | 2017 |
| Bioprinted Blood Brain Barrier Model for Drug Screening CH Sane, G Nzou, AJ Atala TISSUE ENGINEERING PART A 23, S158-S158, 2017 | | 2017 |
Sean V. MurphyAssociate Professor, Wake Forest Institute for Regenerative MedicineVerifierad e-postadress på wakehealth.edu
